Hao Chi
- Cancer Research top 2%
- Cancer-related molecular mechanisms research 15
- MicroRNA in disease regulation 11
- Immunology top 5%
- Immune cells in cancer 12
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 16
- Pancreatic and Hepatic Oncology Research 7
-
- Ferroptosis and cancer prognosis 26
- Molecular Biology top 10%
- Single-cell and spatial transcriptomics 12
- RNA modifications and cancer 10
- Cited by
- Cancer ResearchImmunologyOncology
- Journals
- Frontiers in Immunology (24 papers)Frontiers in Neurology (5 papers)Frontiers in Pharmacology (5 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Hao Chi
111 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 126
- Cancer Research 688
- Immunology 737
- Oncology 820
- Pulmonary and Respiratory Medicine 770
- Molecular Biology 1.1k
Countries citing papers authored by Hao Chi
This map shows the geographic impact of Hao Chi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hao Chi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hao Chi more than expected).
Fields of papers citing papers by Hao Chi
This network shows the impact of papers produced by Hao Chi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hao Chi. The network helps show where Hao Chi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hao Chi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 4 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 13 | |
| 8 | 2023 | 7 | |
| 9 | 2023 | 32 | |
| 10 | 2023 | 40 | |
| 11 | 2023 | 63 | |
| 12 | 2023 | 10 | |
| 13 | T-cell exhaustion signatures characterize the immune landscape and predict HCC prognosis via integrating single-cell RNA-seq and bulk RNA-sequencingbreakdown → | 2023 | 97 |
| 14 | 2023 | 15 | |
| 15 | 2022 | 40 | |
| 16 | 2022 | 31 | |
| 17 | 2022 | 25 | |
| 18 | 2022 | 36 | |
| 19 | 2021 | 23 | |
| 20 | Downregulation of TfR1 promotes progression of colorectal cancer via the JAK/STAT pathway | 2019 | 4 |
About Hao Chi
Hao Chi is a scholar working on Cancer Research, Immunology and Oncology, having authored 120 papers that have together received 2.5k indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (26 papers), Cancer Immunotherapy and Biomarkers (16 papers), Cancer-related molecular mechanisms research (15 papers), Single-cell and spatial transcriptomics (12 papers), Immune cells in cancer (12 papers), MicroRNA in disease regulation (11 papers), RNA modifications and cancer (10 papers) and Pancreatic and Hepatic Oncology Research (7 papers). The work is most often cited by research in Cancer Research (688 citations), Immunology (737 citations) and Oncology (820 citations). Hao Chi has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Zhijia Xia, Gang Tian, Gaoge Peng, Guanhu Yang, Songyun Zhao, Jinhao Zhang, Xixi Xie, Ke Xu, Lai Jiang and Jinyan Yang. Their work appears in journals such as Frontiers in Immunology, Frontiers in Neurology, Frontiers in Pharmacology, Frontiers in Molecular Biosciences and Aging.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.